NEW YORK, March 9 (GenomeWeb News) - Promega and EraGen Biosciences have entered a distribution partnership that gives Promega exclusive rights to quantitative gene expression assays using technology developed by EraGen.

Promega has global distribution rights for the assays. Promega will develop and manufacture reagent systems in its Madison, Wis., facility, while EraGen will provide its patented chemistry and proprietary software for nucleic acid detection.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.